The QualityStocks Daily Stock List
- Kraken Robotics, Inc. (KRKNF)
- Indoor Harvest Corp. (INQD)
- Avalon GloboCare Corp. (AVCO)
- Cardax, Inc. (CDXI)
- Dyadic International, Inc. (DYAI)
- Grom Social Enterprises, Inc. (GRMM)
- Jones Soda Co. (JSDA)
- Sprott, Inc. (SPOXF)
- Towerstream Corp. (TWER)
- Cannabics Pharmaceuticals, Inc. (CNBX)
- Miramont Resources Corp. (MRRMF)
- IronClad Encryption Corporation (IRNC)
- Glance Technologies, Inc. (GLNNF)
- BTCS, Inc. (BTCS)
Kraken Robotics, Inc. (KRKNF)
Spotlight Growth, Ocean News, Stockwatch, Wallet Investor, InvestorsHub, Marine Technology News, OTC Markets, 4-Traders, Barchart, Electric Energy Online, Morningstar, Stockhouse, InvestorsHangout, TradingView, Market Screener, MarketWatch, Seeking Alpha, and GuruFocus reported earlier on Kraken Robotics, Inc. (KRKNF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Kraken Robotics, Inc.’s commitment is to the production and sale of software, sensors, and robotic systems for the international Unmanned Maritime Vehicles market. The Company’s wholly-owned subsidiary is Kraken Robotic Systems, Inc. A marine technology enterprise, Kraken Robotics is based in St. John’s, NL (Newfoundland and Labrador). The Company also has offices in Dartmouth, Nova Scotia; Bremen, Germany; and Fairfax, Virginia. Kraken Robotics lists on the OTC Markets’ OTCQB.
The Company’s wholly-owned subsidiary, Kraken Robotic Systems, Inc., is developing an ultra-wideband acoustic remote sensing system for seafloor imaging and mapping. The AquaPix® Multispectral Synthetic Aperture Sonar (SAS) will be the world’s first commercial SAS to operate over such a wide spectrum, ranging from low audible frequencies to high ultrasonic frequencies.
Kraken Robotics’ series of SAS (Synthetic Aperture Sonar) products named AquaPix® take advantage of almost 20 years of research and development (R&D) conducted by NATO’s Undersea Research Centre and millions of dollars in funding support from NATO government sponsors. AquaPix® provides comparable performance to existing high end military systems at a reduced cost.
AquaPix® can provide detailed seabed images with a constant resolution better than 3cm x 3cm out to a range of 300m from each side of an underwater vehicle (600m swath). It can also produce 3D bathymetric data with a resolution better than 25cm x 25cm out to full range. This is while delivering very high depth accuracy, in compliance with IHO S44 special order requirements.
Furthermore, Kraken Robotics has its DataPod™ product. The design of it is to meet modern data storage requirements for rugged marine applications. DataPod™ combines the user-friendliness of a Network Attached Storage system with the reliability of a RAID array and solid-state storage all in one compact unit. Kraken also has its Kraken SeaVision™ system. This is an inventive new take on subsea 3D laser imaging. The design of it is to operate in a twin scanning configuration, with adjustable baseline. SeaVision can produce very high resolution 3D scans in full color.
Kraken Robotics has expanded from sensors to complete systems. It has introduced its KATFISH™ tethered underwater vehicle. The Company has also introduced the THUNDERFISH® autonomous underwater vehicle (AUV). It also has its AQUATRAK® CVL product. This speed sensor is a derivative of its SAS technology and is for the oil and gas sector for ROVs.
In January, Kraken Robotics announced that it completed the majority acquisition of Kraken Power GmbH. Via the conversion of an existing note receivable to equity and a cash payment of roughly €0.1 million, Kraken increased its ownership in Kraken Power GmbH to 75 percent. Kraken Power GmbH (Rostock, Germany) employs a 20-person team consisting of highly skilled engineers, technicians and administration staff.
Today, Kraken Robotics announced that its wholly-owned subsidiary, Kraken Robotic Systems, Inc., received purchase orders for about $1.7 million from Ocean Infinity for Kraken’s AquaPix® Synthetic Aperture Sonar (SAS) sensors and support. This is the second set of purchase orders from Ocean Infinity under an initial master agreement contract announced in Q3 of 2017.
Kraken Robotics, Inc. (KRKNF), closed Tuesday's trading session at $0.51, down 1.26%, on 94,027 volume with 54 trades. The average volume for the last 3 months is 45,825 and the stock's 52-week low/high is $0.10644/$0.535.
Indoor Harvest Corp. (INQD)
Orbit Stocks, Awesome Penny Stocks, CFN Media Group, InvestorsHub, Stockhouse, Cannabis Financial Network News, Massive Stock Profits, Make Penny Stocks Great Again, SmallCapVoice, MarketWatch, Microcap Daily, Fast Money Alerts, Stock Shock and Awe, OTPicks, Penny Stock General, and PennyPickAlerts reported earlier on Indoor Harvest Corp. (INQD), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Indoor Harvest Corp. is a developer of personalized cannabis medicines. In addition, the Company is a provider of advanced cultivation technology, methods, and processes. Indoor Harvest provides the cannabis industry production platforms for Building Integrated Agriculture (BIA) production. Established in 2011, the Company has its corporate headquarters in Houston, Texas. It is now moving its base of operations and focus to the Boston, Massachusetts area to leverage what it believes to be an attractive environment for cannabis companies since Massachusetts has legalized medicinal and recreational cannabis.
Indoor Harvest has transitioned into a producer of cannabis for research and pharmaceutical development. The Company’s patent pending aeroponic methods allow for the production of chemically consistent, contaminate free cannabis, economically at scale.
Indoor Harvest is a pending applicant to produce cannabis under the Texas Compassionate Use Program and is seeking additional licenses in the State of Massachusetts. The Company is moving its operational emphasis to Boston, Massachusetts.
Indoor Harvest has entered into a non-binding Memorandum of Understanding (MOU) to explore the creation of a joint venture (JV) partnership with Cannabis Community Care and Research Network (C3RN) and Integrated Genetics & BioPharma Research (IGBR). Indoor Harvest’s plan is to work with C3RN and IGBR to develop a plan to acquire or lease properties and pursue research and development (R&D) initiatives. Additionally, the Company expects to have the ability to offer contract research services and product development services to the cannabis community at large.
The proposed JV will work to identify and publish best practices for cultivation of cannabis via rigorous R&D. Moreover, the JV group aims to provide data and develop partner-specific research studies and goals with academic and other research institutions.
Indoor Harvest’s Management is working to deploy its integrated aeroponic technology platform, on its own and with partners in the Boston area, to demonstrate and highlight the Company’s belief in the technology’s ability to considerably decrease operating costs while boosting yield and quality.
Indoor Harvest Corp. (INQD), closed Tuesday's trading session at $0.0494, up 7.63%, on 192,073 volume with 38 trades. The average volume for the last 3 months is 166,763 and the stock's 52-week low/high is $0.0305/$0.288.
Avalon GloboCare Corp. (AVCO)
NetworkNewsWire, Real Investment Advice, InvestorsHub, Stockwatch, Penny Stock Hub, OTC Markets, Information Vine, Wolf Street, Wallet Investor, Simply Wall St, Dividend Investor, Trading View, Dynamic Wealth Research, Business Insider, Investors Hangout, Proactive Investors, and Whale Wisdom reported previously on Avalon GloboCare Corp. (AVCO), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Avalon GloboCare Corp. provides healthcare services in the United States and China. The Company operates by way of its primary platforms: Avalon Cell and Avalon Rehabilitation. The Company is a premier healthcare management provider and biotechnology developer. Its dedication is to integrate and manage global healthcare resources. Avalon GloboCare is headquartered in Freehold, New Jersey.
The Company has established a new wholly-owned U.S. subsidiary, Avactis Biosciences, Inc. This subsidiary will center on fast-tracking commercial activities related to its proprietary Chimeric Antigen Receptor (CAR)-T technologies.
Furthermore, Avalon GloboCare has formed a strategic partnership with Weill Cornell’s cGMP Cellular Therapy Facility and Laboratory for Advanced Cellular Engineering headed by Dr. Yen-Michael Hsu. This strategic partnership aims to co-develop bio-production and standardization procedures in procurement, storage, processing, clinical study protocols, and bio-banking for Chimeric Antigen Receptor (CAR)-T therapy, in accordance with the Foundation of Accreditation for Cellular Therapy (FACT) and American Association of Blood Banks (AABB) standards.
Avalon GloboCare, via its subsidiary, “Avalon RT9 Properties, LLC”, involves in the acquirement and management of healthcare facilities. Concerning the Company’s healthcare facility, it presently includes healthcare property management services, chiefly through acquiring and managing healthcare real estate facilities, stem cell banks, and a CAP-certified laboratory, which will complement its existing platforms.
The “Avalon Rehabilitation” platform is a turnkey, comprehensive set of rehabilitation services. These services include PT, OT, robotic engineering, cybernectics, and clinical nutrition. The “Avalon Cell” platform centers on cell-based therapies and technologies. Its emphasis is in the field of in vitro diagnostics, regenerative medicine, as well as cancer immunotherapy.
Avalon Cell focuses on transformative and high-impact cell-based bio-technology opportunities in the United States and China. It subsequently fast tracks these to clinical development and commercialization around the world.
Avalon GloboCare’s majority-owned subsidiary is GenExosome Technologies, Inc. GenExosome acquired 100 percent of the outstanding capital stock of Beijing Jieteng (Beijing GenExosome) Biotech Co. Ltd. GenExosome also entered into and closed an Asset Purchase Agreement with Dr. Yu Zhou, Chief Executive Officer of GenExosome Beijing, where GenExosome acquired all assets, including all intellectual property (IP), patents and patent applications held by Dr. Zhou regarding the researching, developing, and commercializing exosome technologies.
Moreover, Avalon GloboCare has its Epicon Biotech Co. Ltd. joint venture (JV) with Jiangsu Unicorn Biological Technology Co. Ltd., within the Nanjing BenQ Hospital. This is a prestigious Grade 3A medical center in Jiangsu Province, China. Avalon formed the JV with Jiangsu Unicorn to create a provincial network of translational cellular therapies and bio-banking programs.
Last month, Avalon GloboCare and its subsidiary Genexosome Technologies announced the discovery and development of the world’s first saliva-based exosomal microRNA biomarker, miR-185, as a dual diagnostic and therapeutic target for oral cancer. In collaboration with Beijing Stomatological Hospital affiliated with the Capital Medical University in China, Avalon GloboCare and Genexosome Technologies completed a clinical study and revealed miR185 as a novel saliva-based exosomal biomarker with strong correlation and predictive value for malignant transformation from oral leukoplakia to oral cancer.
Last week, Avalon GloboCare announced that its continuing co-development program with Weill Cornell Medicine, led by Yen-Michael Hsu, M.D., Ph.D., Director of cGMP Cellular Therapy Facility and Laboratory for Advanced Cellular Engineering, identified novel human angiogenic exosomes/extracellular cellular vesicles (EV) derived from endothelial cells. The angiogenic exosomes contain angiogenic factors developed to promote new blood vessel formation and tissue regeneration upon release from exosomes.
Avalon GloboCare Corp. (AVCO), closed Tuesday's trading session at $3.96, down 6.38%, on 171,501 volume with 1,440 trades. The average volume for the last 3 months is 689,580 and the stock's 52-week low/high is $0.984/$13.50.
Cardax, Inc. (CDXI)
Zacks, Street Insider, The Street, 4-Traders, Stockopedia, Morningstar, InvestorsHub, Market Exclusive, MarketWatch, GuruFocus, last10k, Barchart, Stockhouse, and Street Insider reported earlier on Cardax, Inc. (CDXI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cardax, Inc. is a development stage Life Sciences Company listed on the OTCQB. It dedicates primarily all its efforts to developing consumer health and pharmaceutical products that it believes will provide many of the anti-inflammatory benefits of steroids or NSAIDS through targeting many of the same inflammatory pathways and mediators, however with exceptional safety profiles. Cardax has its corporate headquarters in Honolulu, Hawaii.
The Company is preparing proprietary nature-identical products and related derivatives via total synthesis to provide scalable, pure, and economical therapies for diseases where inflammation and oxidative stress are strongly implicated. This includes, but is not limited to, osteoarthritis, rheumatoid arthritis, dyslipidemia, metabolic disease, diabetes, cardiovascular disease, hepatitis, cognitive decline, macular degeneration, and prostate disease.
Cardax’s initial main focus is its astaxanthin technologies. Astaxanthin is a strong and safe, naturally occurring, anti-inflammatory and anti-oxidant without the adverse side effects characteristic of anti-inflammatory treatments using steroids or NSAIDS (including immune system suppression, liver damage, cardiovascular disease risk, and gastrointestinal bleeding).
The Company’s ZanthoSyn® is its first product to help consumers safely address their inflammatory health. Cardax says that ZanthoSyn® is a physician recommended, anti-inflammatory supplement for health and longevity that features astaxanthin with optimal absorption and purity. ZanthoSyn® contains astaxanthin, which is Generally Recognized as Safe (GRAS) according to Food and Drug Administration (FDA) regulations. The safety and efficacy of the Company’s product candidates have not been directly evaluated in clinical trials or confirmed by the FDA.
This past October, Cardax announced it launched its Cardiovascular Health Astaxanthin Supplement Evaluation (CHASE) clinical trial targeting cardiovascular inflammatory health. The first subject was dosed on September 19, 2018. This randomized, double-blind, placebo-controlled CHASE clinical trial will evaluate the effect of low-dose and high-dose ZanthoSyn® on cardiovascular health, as measured by C-Reactive Protein (CRP) levels, over 12 weeks in up to 360 subjects with documented cardiovascular risk factors. Additionally, the study will include an optional open label extension through 48 weeks.
In December 2018, Cardax and GNC announced that they are expanding the sales and marketing program for ZanthoSyn®. GNC is the exclusive brick-and-mortar retail channel for ZanthoSyn®. GNC will augment Cardax's sales and marketing efforts with additional initiatives to boost ZanthoSyn® product awareness and education among GNC store associates and customers nationwide.
Cardax, Inc. (CDXI), closed Tuesday's trading session at $0.19, up 5.56%, on 30,588 volume with 6 trades. The average volume for the last 3 months is 16,393 and the stock's 52-week low/high is $0.17/$0.44.
Dyadic International, Inc. (DYAI)
Stockflare, Zacks, Street Insider, Stockopedia, MarketWatch, Morningstar, Corporate Connect, Equity Clock, GuruFocus, Proactive Investors, Investors Hub, MicroCapDaily, YCharts, Journal Transcript, Capital Cube, Stockhouse, and Market Screener reported earlier on Dyadic International, Inc. (DYAI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Dyadic International, Inc. is a global biotechnology company listed on the OTC Markets’ OTCQX. Its emphasis is on further improving and applying its proprietary C1 gene expression platform to speed up the development and lessen the cost of biologic vaccines and drugs at flexible commercial scales. Dyadic International has a foreign subsidiary, Dyadic Nederland, BV, which maintains a small satellite office in Wageningen, the Netherlands. Dyadic International has its corporate office in Jupiter, Florida.
Dyadic International has developed a method for producing commercial quantities of enzymes and other proteins needed for the production of industrial enzymes. The Company has successfully licensed this technology to third parties including Abengoa Bioenergy, BASF, Codexis and others.
The foundation of the technology is on the Myceliophthora thermophila fungus that Dyadic named C1. The C1 technology is a strong and versatile fungal expression system for gene discovery, development, expression and production of enzymes and other proteins.
The Company’s C1 Expression System is an optimized and industrially proven system. It turns genes into a wide array of valuable products. The C1 Technology Platform helps to overcome some of the inadequacies of existing expression technologies used for gene discovery, product development and commercialization. Dyadic is seeking research collaborations, government funding, partners, and sub-licensees in which to apply the C1 platform in the vaccine, antibody, biosimilar and biobetters industries.
Last month, Dyadic International announced it was named to the 2019 OTCQX® Best 50. This is a ranking of top performing companies traded on the OTCQX Best Market in 2018. The OTCQX Best 50 is an annual ranking of the top 50 U.S. and international companies traded on the OTCQX market. The ranking is calculated based on an equal weighting of one-year total return and average daily dollar volume growth in the prior calendar year. Companies in the 2019 OTCQX Best 50 were ranked based on their performance last year.
Dyadic International, Inc. (DYAI), closed Tuesday's trading session at $2.38, up 3.48%, on 56,230 volume with 68 trades. The average volume for the last 3 months is 29,940 and the stock's 52-week low/high is $1.39/$2.33.
Grom Social Enterprises, Inc. (GRMM)
Stockopedia, TradingView, Barchart, Wall Street Analyzer, InvestorsHub, New Media Wire, Business Insider, last10k, Street Insider, Canadian Insider, Wallet Investor, YCharts, Stockhouse, Marketwired, Insider Tracking, and Dividend Investor reported earlier on Grom Social Enterprises, Inc. (GRMM), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Grom Social Enterprises, Inc. wholly owns various separate subsidiaries. This includes Grom Social - a safe social media platform for children between the ages of five and 16. Grom Social has attracted children and parents with the promise of a safe and secure environment where their children can be entertained and can interact with their peers while learning proper digital citizenship.
Grom Social Enterprises has its head office in Boca Raton, Florida. Furthermore, the Company owns and operates Top Draw Animation, Inc. This is an award-winning animation enterprise. Top Draw Animation produces animated content for Grom Social and other high-profile media properties.
Grom also has its MamaBear Mobile/Desktop Application. MamaBear is the unique, mobile, all-in one parenting app. It creates a private family communication hub. Families communicate, locate, organize, and protect their children with peace of mind. Moreover, the Company’s Grom Nutritional Services has its Just Brilliant offering. This is a nutritional supplement formulated to provide dietary supplementation of selected nutrients.
Regarding Grom Social, children can create a profile; make friends, talk, and share content. Grom is a social community with a broad variety of original content and engaging features. These include exclusive Grom TV videos, fun Grom games, interesting photos, and thought provoking Fan Pages.
Inappropriate content or behavior on Grom Social is identified by digital filters and the Company’s cast of Grom Helpers. Grom Helpers are real people who monitor the website 24 hours a day, 7 days a week, 365 days a year.
Grom Social has its Parent Portal. This is a tool available to parents and guardians. The Parent Portal enables parents and guardians to monitor and control all of their child’s activity on Grom Social. Parents can set privacy settings; examine chat histories; and review and control who their child is friends with.
Grom Social Enterprises also has its Grom Educational Services (GES) subsidiary. GES opened a 1,400 square foot office in Norcross, Georgia on January 1, 2018. This is to house its NetSpective WebFilter division. NetSpective WebFilter provides protection and security for schools and students meeting and exceeding CIPA requirements for technology protection measures and internet safety policies, which include filtering and monitoring the online activities of minors/students.
Grom Social Enterprises plans to launch a set of enterprise-level PaaS (Platform-as-a-Service) solutions employing its safe and secure social network for children. The solutions will enable Grom Social to partner with mobile carriers, entertainment networks, social networks, community marketplaces and online platforms to enhance the content and security experience for kids.
In January, Grom Social Enterprises announced that its Top Draw Animation subsidiary secured another contract to produce a high profile series valued at $2.2 million. Grom also announced in January that its Top Draw Animation subsidiary secured an additional production commitment for an ongoing TV series. Therefore, Top Draw’s U.S. contracts are at record levels and it continues to pursue new business.
Grom Social Enterprises, Inc. (GRMM), closed Tuesday's trading session at $0.2549, even for the day. The average volume for the last 3 months is 11,368 and the stock's 52-week low/high is $0.10/$0.96.
Jones Soda Co. (JSDA)
Actual Gains, MarketWatch, Stock Twits, The Street, Wealthpire, Investor Update, SmallCapVoice, PennyStockRumors, PricelessPennyStocks, SmarTrend Newsletters, TopStockAnalysts, Stock Analyzer, SuperNova Elite, Dividend Opportunities, and Stockhouse reported previously on Jones Soda Co. (JSDA), and today we are highlighting Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Jones Soda Co. is a leader in the premium soda category. The Company has a reputation for its unique flavors and branding. Jones Soda markets and distributes premium beverages under the Jones® Soda, Jones Zilch®, and Lemoncocco™ brands. Jones Soda sells across North America in glass bottles, cans and on fountain through traditional beverage outlets, restaurants, and alternative accounts. The Company is based in Seattle, Washington. Jones Beverages International is a subsidiary of Jones Soda.
Jones Soda is made with pure cane sugar. The Company’s varied product line includes pure cane sugar soda, zero-calorie soda, and an all-naturally sweetened sparkling beverage with only 30 calories and 8 grams of sugar.
The Jones Soda portfolio includes Jones Pure Cane Soda, Jones Sugar Free, Jones Cane Sugar fountain products, Spiked Jones (a hard cider soda created for the Company’s 21+ market) and its sister brand Lemoncocco, which is a non-carbonated beverage inspired by the icon beverage stands in Rome, Italy. The Lemoncocco™ product is flavored with the extracts of Sicilian lemons and a bit of coconut cream. Lemoncocco™ is a natural beverage, lightly sweetened with a little cane sugar. It is 90 calories per 12 ounce serving. Moreover, it is dairy free and gluten free.
7-Eleven, Inc. and Jones Soda have partnered and created 7-Select® brand premium sodas crafted by Jones. This is the first premium carbonated beverage in the 7-Select private brand line-up. Each 7-Select premium soda is made with natural flavors, lightly sweetened with cane sugar, and ranges from only 180 to 195 calories per 20-ounce bottle. This brand includes 75 mg. of caffeine in each serving.
In January, Jones Soda announced it launched Jones Ginger Beer and two new sugar free soda flavors. This is while transitioning to natural colors and natural flavors in most of its glass bottle portfolio. Unique to Jones Ginger Beer is its signature packaging. This packaging includes a resealable cap that makes this offering ideal for foodservice accounts. In addition, Jones Soda is adding sugar free versions of Strawberry Lime and Cream Soda, two of its top-selling flavors, to its United States portfolio.
Jones Soda Co. (JSDA), closed Tuesday's trading session at $0.375, up 8.62%, on 117,254 volume with 38 trades. The average volume for the last 3 months is 65,296 and the stock's 52-week low/high is $0.219/$0.529.
Sprott, Inc. (SPOXF)
StreetInsider, Stockhouse, InvestorsHub, Stock Gumshoe, Stockwatch, 4-Traders, The Street, and Tip Ranks reported on Sprott, Inc. (SPOXF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Sprott, Inc. provides investors with access to highly-differentiated precious metals and real assets investment strategies. A global asset manager, the Company’s best-in-class investment products include innovative physical bullion trusts, mining ETFs (Exchange-Traded Funds), and private equity and debt strategies.
Sprott is based in Toronto, Ontario. In addition, it has offices in Connecticut, Carlsbad, California, and Vancouver, British Columbia. The Company’s shares trade on the OTC Markets.
Sprott also partners with natural resource companies to meet their capital requirements via its merchant banking and resource lending activities. The Company was established in 1981 by Mr. Eric Sprott, an early champion of precious metals and real assets investing.
Today, Sprott serves more than 200,000 global clients. Furthermore, the Company has greater than C$11.5 billion in assets under management after the acquisition of Central Fund of Canada Limited.
Sprott’s unique capabilities allow it to provide flexible financing solutions across the mining life cycle. Its capabilities also allow it to match international investor demand with a strong pipeline of investment opportunities.
Regarding Wealth Management, Sprott provides wealth management services to U.S., Canadian, and international clients by way of its subsidiaries - Sprott US and Sprott Private Wealth.
Concerning Asset Management, the Company offers Sprott Physical Bullion Trusts, Sprott ETFs, and Actively-Managed Strategies. Pertaining to Resource Financing, Sprott has its Sprott Resource Lending, Sprott Capital Partners, and Sprott Resource Holdings.
Through its subsidiaries, the Company provides asset management, portfolio management, wealth management, fund management, and administrative and consulting services to its clients. Sprott offers mutual funds, hedge funds, and offshore funds, along with managed accounts. Moreover, the Company provides broker-dealer activities.
Recently, Sprott announced its financial results for the three months ended June 30, 2018.
Mr. Peter Grosskopf, Sprott Chief Executive Officer, said, "The second quarter of 2018 was steady both in terms of our financial performance and ongoing investment in new growth initiatives. The Company's profitability continues to improve due largely to growth in our Exchange Listed Products business from the acquisition of Central Fund of Canada Ltd., as well as additional capital calls in our Private Resource Lending funds. On a normalized basis, Adjusted Base EBITDA increased by more than 40 percent during the quarter and more than 50 percent in the first half of the year."
Sprott, Inc. (SPOXF), closed Tuesday's trading session at $1.97, up 3.14%, on 294,977 volume with 271 trades. The average volume for the last 3 months is 261,016 and the stock's 52-week low/high is $1.75/$3.29.
Towerstream Corp. (TWER)
KingPennyStocks, ChartPoppers, BUYINS.NET, Damn Good Penny Picks, Penny Stock Prodigy, CoolPennyStocks, Epic Stock Picks, Hit and Run Candle Sticks, HotOTC, MadPennyStocks, MarketClub Analysis, Money Morning, OTCBB Journal, OTCMagic, Penny Picks, Investing Futures, MicroCapDaily, Investment Contrarians, Jason Bond, Broad Street, BullRally, PennyInvest, and PennyOmega reported on Towerstream Corp. (TWER), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Towerstream Corp. is a foremost Fixed-Wireless Fiber Alternative business. The Company delivers high-speed Internet access to businesses. Together with its subsidiaries, it provides fixed wireless broadband services and delivers access over a wireless network transmitting over regulated and unregulated radio spectrum to commercial customers in the U.S. OTCQB-listed, Towerstream is based in Middletown, Rhode Island.
Earlier this year, Towerstream announced that its Board commenced evaluation of strategic repositioning of the Company as it moves to leverage its existing important assets in major United States markets. In association with the announcement, Towerstream launched a determined focus on indirect and wholesale channels and the retention of Bank Street Group LLC as its independent financial advisor to explore strategic alternatives with such broadband carriers.
The Company provides broadband services in twelve urban markets. These include New York City, Boston, Los Angeles, Chicago, Philadelphia, the San Francisco Bay area, Miami, Seattle, Dallas-Fort Worth, Houston, Las Vegas-Reno, and the greater Providence area. Towerstream has built 175 Major Points of Presence (POPs). It positions its POPs on the tops of buildings.
Towerstream is a last-mile facilities-based provider. The Company owns its entire network. Towerstream completely bypasses the local exchange carrier and cable providers. Towerstream’s solution to businesses either complements or replaces existing Internet connections.
The Company provides property managers, building owners, and their commercial tenants a redundant and reliable dense urban network. This network directly connects to Towerstream’s fiber backbone.
Towerstream has its Single Tenant Internet Solution. This solution is for customers not in On-Net buildings. The Single Tenant Internet Solution provides primary and back-up dedicated internet access as a speedier and less costly alternative to fiber.
On-Net refers to the extensive number of buildings in the Company’s 12 coverage markets currently lit for On-Net Business Internet Service. Towerstream’s On-Net Service provides businesses within its continually increasing portfolio of On-Net buildings with dedicated and symmetrical Internet connectivity.
Towerstream anticipates future operating efficiencies resulting from scale and optimization initiatives. The Company’s network footprint can reach 392,000 buildings within a 4 mile radius of its PoPs. Towerstream can serve customers at 10-13 miles. Towerstream announced a new wholesale division in August of 2017 to take advantage of its existing footprint and timely installation capability to provide last-mile service to carriers.
Towerstream Corp. (TWER), closed Tuesday's trading session at $1.10, up 0.92%, on 621 volume with 6 trades. The average volume for the last 3 months is 820 and the stock's 52-week low/high is $1.09/$15.00.
Cannabics Pharmaceuticals, Inc. (CNBX)
SmallCapVoice, StreetAuthority Daily, Wall Street Daily, TopPennyStockMovers, Stockgoodies, Promotion Stock Secrets, Cannabis Financial Network News, Wealth Insider Alert, Wall Street Mover, Market Intelligence Center, and TheMicrocapNews reported on Cannabics Pharmaceuticals, Inc. (CNBX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cannabics Pharmaceuticals, Inc.’s dedication is to the development of advanced cannabinoid-based treatments and therapies. Its main emphasis is the development of novel therapies and biotechnological tools designed to provide relief from various ailments and treat human malignancies. The Company’s vision is to create individually tailored natural therapies for cancer patients, using advanced screening systems and personalized bioinformatics tools. Cannabics Pharmaceuticals has its corporate office in Bethesda, Maryland.
The Company has licensed Research and Development (R&D) headquartered in Israel. This R&D’s commitment is to the development of palliative and personalized anti-cancer treatments channelling the multipurpose therapeutic values of cannabinoids to create tailored therapies for cancer patients.
Cannabics’ integrated technology has created a successful medically standardized delivery system providing patients natural, reliable, and safe therapy. The Company has created a Genetic lab. This lab will develop diagnostic tools based on human genome, tumor genetics, as well as cannabinoids.
Cannabics’ advanced tools include novel delivery systems, personalized medicine diagnostics, and therapies based on cannabinoid compounds. The Company’s chief technology is Cannabics SR. This technology is for a long acting oil capsule, which provides a safe, effective, and reliable administration of cannabis. The technology’s composition is exclusively from food grade materials.
Cannabics Pharmaceuticals announced this past May that the Chief Executive Officer of Life Source Partners Ltd., Muriel Zohar, PhD, MBA, will be working with Cannabics to advance personalized and palliative cannabinoid cancer care. In addition to assessing project opportunities, Dr. Zohar will support the management of a new Cannabics equity line.
Recently, Cannabics Pharmaceuticals announced that it concluded its clinical trial held at Rambam Medical Center. The Oncology Center at Rambam Medical Center is recognized by the European Society for Medical Oncology (ESMO) as a designated Center of Integrated Oncology and Palliative Care.
Eyal Ballan, Cannabics Pharmaceuticals’ Chief Technical Officer, said, "We are very pleased to have completed this study. We are awaiting the results and expect them to further elucidate an important aspect of our mission in integrating cannabinoid-based therapies into the world of precision medicine; while at the same time focusing our efforts on bringing scientific data to support developments of cannabinoid-based therapies".
Recently, Cannabics Pharmaceuticals announced that it officially moved into its new state-of-the-art Cancer Screening Laboratory located in Rehovot, Israel. The Company and its new Laboratory are broadly licensed by the Ministry of Health in Israel specifically for R&D on Cannabis.
Cannabics' agreement with a company engaged in ophthalmic disorders to develop a product to compete with Steroids in the ocular disease market. Furthermore, the Company is expecting the final report from Prof. Gil Bar-Sela of Rambam Hospital from its clinical trial on cancer patients of its SR capsule for Cachexia and Anorexia.
Recently, Cannabics Pharmaceuticals announced a partnership agreement with Eroll Grow Tech ltd (Seedo), developer of the world's first fully-automated grow device designed specifically for cannabis. Via this new partnership, Cannabics Pharmaceuticals and Seedo will develop the first controlled device for growing medical cannabis at home, ensuring sustainable quality and supply of natural, pesticide free product.
Cannabics Pharmaceuticals, Inc. (CNBX), closed Tuesday's trading session at $0.4099, up 6.19%, on 142,453 volume with 141 trades. The average volume for the last 3 months is 224,861 and the stock's 52-week low/high is $0.27/$1.58.
Miramont Resources Corp. (MRRMF)
Stockhouse, Stockwatch, Wallet Investor, InvestorX, Global Mining Review, Junior Mining Network, MarketWatch, Dividend Investor, Canadian Mining Report, OTC Markets, Pinnacle Digest, Wallmine and 4-Traders reported on Miramont Resources Corp. (MRRMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Miramont Resources Corp. engages in the exploration and development of its Peruvian projects. Its emphasis is on acquiring and developing mineral prospects within world-class belts of South America. The Company was previously known as Miramont Capital Corp. It changed its name to Miramont Resources Corp. in November of 2016. Miramont Resources has its corporate office in Vancouver, British Columbia.
The Company entered into a share exchange agreement in June of 2017 to acquire 100 percent of Puno Gold Corp., a privately held Ontario corporation, and Minera Puno Gold SAC, a Peruvian subsidiary of Puno Gold. Minera Puno engages in mineral exploration and development in Peru. It holds options to acquire 100 percent interest in the 988.69-hectare Cerro Hermoso project and the 4,400-hectare Lukkacha project (both in southern Peru).
Cerro Hermoso is in the Puno region, 60 kilometers west of the city of Juliaca, and 5kms west of the supply town of Santa Lucia. Cerro Hermoso is a breccia-pipe prospect targeting Au, Ag, Cu, Zn and Pb mineralization.
Lukkacha is in the Tacna region. It is 55 kilometers east-southeast of the operating Toquepala mine of Southern Peru Copper. The project (a porphyry copper prospect) is 60 kilometers north of the city of Tacna and 8 kilometers from the supply town of Tarata.
Recently, Miramont Resources announced that it entered into an option agreement to acquire the rights to the Milenos 32 concession contiguous to its Cerro Hermoso project. The concession gives the Company complete control of the Pocomoro zone. This is where highly anomalous copper and silver has been identified in surface rock samples. The combined area of the project is currently 1318 hectares. It includes the whole diatreme system, which controls mineralization in the district.
Also, Miramont Resources announced that the Peruvian Ministry of Energy and Mines (MEM) determined that Miramont is not eligible for an automatic approval of its drilling permit as it is possible that exploration drilling may affect indigenous communities. The Company stated that it appreciates more review to ensure that any potentially affected communities are identified and fully consulted. As Miramont Resources’ Environmental Impact Statement has already been approved, this is the final level of review required before issuance of drilling permits.
Miramont Resources Corp. (MRRMF), closed Tuesday's trading session at $0.297, even for the day, on 41,500 volume with 10 trades. The average volume for the last 3 months is 46,387 and the stock's 52-week low/high is $0.116/$0.349.
IronClad Encryption Corporation (IRNC)
InvestorsHub, OTC Markets, YCharts, Barchart, Investors Hangout, Stock News Now, TradingView, The Street, Simply Wall St, MarketWatch, 4-Traders, and PennyStockHub reported on IronClad Encryption Corporation (IRNC), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
IronClad Encryption Corporation is a next-generation cyber defense company based in Houston, Texas. Its strategic and tactical data protection solutions strengthen existing encryption methods. The Company’s technology can provide continuous authentication of encrypted data transmitted, creating much stronger defenses to most hacker attacks. IronClad Encryption’s shares trade on the OTC Markets’ OTCQB.
IronClad Encryption-powered solutions use the Company’s patented Dynamic Encryption and Perpetual Authentication technologies to make all known key-based encryption technologies almost impossible to compromise. Dynamic Encryption Technology eliminates vulnerabilities caused by exposure of any single encryption key through continually changing encryption keys and keeping the keys synchronized in a fault-tolerant way.
Dynamic Encryption technology eliminates the single point of failure problem inherent in single-key encryption techniques. IronClad’s key management system continuously produces synchronous keys between the sender and receiver. Each key is assigned to a small amount of data. Therefore, if a hacker were to access one of hundreds of millions of keys, the amount of data he would obtain would be almost useless.
IronClad Encryption offers its ICEMicro. This is the world’s first context-free and natively-secure container. It enables all developers to take ownership of application data security. Using ICEMicro, any developer can secure communication between containers across varied scheduling and orchestration platforms, IaaS services, transport-layer security protocols, and on-premises or hybrid environments utilizing Docker-compatible hypervisors. ICEMicro gives DevOps teams a way to build, install, and run secure applications without the costs associated with legacy security strategies.
IronClad Encryption has partnered with Black Pearl Engineering Management, Inc. to co-develop ultra-secure products based on IronClad’s patented ultra-secure cybersecurity algorithms and methodologies. The joint venture (JV) operates under the name "Black ICE". It is first focusing on network gateway products.
The Black ICE Programmable Logic Control (PLC) / Network Gateway product line specifically targets the Industrial Control System security market. The new product line is an intelligent management system. It will integrate IronClad Encryption’s patented ultra-secure algorithms and methodologies in a package, which can be easily and seamlessly integrated into an existing infrastructure.
BlackICE Barrier is the first product in a family of BlackICE products. BlackICE Barrier is specifically targeted at enterprises and industrial use cases where data and control systems require the highest level of security.
Regarding the Company’s solutions, IronClad Encryption provides fine-grain access control. As such, customers can put "rings" around a desktop computer, laptop, or server to control data access. For instance, a team of people operating within a ring could be authorized to view documents but not allowed to download or transfer those documents. Moreover, the rings support multifactor authentication. In addition, they can be used to enforce multiparty authorization by 2 to 64 parties.
IronClad Encryption Corporation (IRNC), closed Tuesday's trading session at $0.046, up 15.00%, on 1,425,427 volume with 100 trades. The average volume for the last 3 months is 178,138 and the stock's 52-week low/high is $0.029/$2.25.
Glance Technologies, Inc. (GLNNF)
MarketWatch, Evergreen Caller, InvestorsHub, and Emerging Growth reported on Glance Technologies, Inc. (GLNNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Glance Technologies, Inc. owns and operates Glance Pay. This is a streamlined payment system. It transforms how smartphone users choose where to dine, order food and drink, settle bills, access digital receipts, earn excellent rewards, and interact with merchants. Regarding the Glance Pay mobile payment app, there is no set up or cancellation fees and no system integration or connections required. Glance Technologies has its corporate headquarters in Vancouver, British Columbia.
The Company is building a valuable network of merchants and consumers. Glance offers targeted in-app marketing, social media marketing, customer feedback, in-merchant messaging, as well as custom rewards programs.
The Glance Pay mobile payment system comprises proprietary technology. This technology includes user apps available for free downloads in IOS (Apple) and Android formats, a merchant manager apps, a large-scale technology hosting environment with sophisticated anti-fraud technology, and very quick payment processing.
The Glance Pay mobile payment app works for full service restaurants, quick serve, retail, and more. It also features easy activation and training and easy automatic accounting and reconciliation, and fast payment deposits. Servers and managers can review transaction details.
This week, Glance Technologies announced that it agreed to license its mobile payment technology to Active Pay Distribution, Inc. for $1,000,000. This marks Glance Technologies’ entry into the fitness hand wellness market.
With this deal, Glance Pay will create and provide the technology backbone for the Active Pay app that will serve the increasing fitness and wellness community. The app will be called Active Pay. It will be uniquely branded as Active Pay. However, it will be labeled as "powered by Glance Pay".
Additionally, merchants and users who sign up for the Active Pay app will be included in the Glance Pay app. Glance Technologies (in addition to the $1 million license fee) will receive a processing fee for transactions and a percentage of revenues generated via the Active Pay app.
Recently, Glance Technologies announced that in-app digital offer concept marketing is now available to merchants and business partners. Users can redeem exclusive offers and discounts set by the retailer by way of the Company’s Deals Room directly on the Glance Pay app, lessening the need for expensive traditional paper deals, coupons, and expired email offers, while simultaneously providing creativity and flexibility for deals that are not feasible through traditional methods.
Users will continue to save time with Glance Pay by paying and leaving quicker. They now have offers to make speedier decisions on where to spend their time and money.
Glance Technologies, Inc. (GLNNF), closed Tuesday's trading session at $0.1433, up 24.66%, on 398,776 volume with 93 trades. The average volume for the last 3 months is 288,513 and the stock's 52-week low/high is $0.0742/$0.857.
BTCS, Inc. (BTCS)
RedChip, PennyPro, Stock Commander, HotStockProfits, Value Penny Stocks, Money Morning, 1-2-3 Stock Alerts, Fortune Stock Alerts, Penny Stock Circle, StockMarketQuote.us, StockMister, SmallCapVoice, AddictivePennyStocks, Bullseyestox.com, PennyStockRumors.net, PennyStocks Forever, PricelessPenny, and TheMicrocapNews reported on BTCS, Inc. (BTCS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
BTCS, Inc. is a blockchain technology focused company headquartered in Silver Spring, Maryland. The Company is an early entrant in the Digital Asset market. In addition, it is one of the first U.S. publicly traded companies engaged with Digital Assets and blockchain technologies. Blockchains are distributed public ledgers, which can fundamentally influence all industries around the world that require trust and rely on or use record keeping. The Company has a record of accomplishment of accurate digital asset trend prediction. BTCS’ shares trade on the OTC Markets Group’s OTCQB.
BTCS’ plan (subject to additional financing) is to create a portfolio of digital assets, such as bitcoin and other "protocol tokens", to provide investors a diversified pure-play exposure to the bitcoin and blockchain industries. The Company’s intention is to acquire digital assets by way of open market purchases; and participating in initial digital asset offerings (or initial coin offerings).
Furthermore, BTCS may acquire digital assets through resuming its transaction verification services business (or mining) via outsourced data centers and earning rewards in digital assets by securing their respective blockchains. Moreover, the Company is concentrating on growth via acquisition.
A blockchain is secured and maintained by a network of specialized servers (nodes) globally. All transactions are publicly available on a blockchain. Transactions undergo verification and confirmation through nodes worldwide before being added to a blockchain.
Recently, BTCS announced the appointment of Mr. Jonathon R. Read to its Board of Directors. Mr. Read has held many executive positions with domestic and global companies over a career, which spans more than 35 years. Also recently, from 2013 to the present, he has served as Managing Partner of Quadratam1 LLC (Scottsdale, Arizona) a firm specializing in providing financial and organizational consulting services for growth-stage companies in the United States and China.
Before that, Mr. Read served as Chief Executive Officer (CEO) or President of Timefire VR, Inc., previously known as EnergyTek Corp. During his tenure, he repositioned, re-financed, and merged the company into an entity centered on the virtual reality sector.
Mr. Charles Allen, BTCS CEO, said, "Jonathon brings a wealth of public company expertise to our board. As we move forward on our plans to build a vertically-integrated operation in the burgeoning blockchain space, Jonathon's experience should add tremendous value."
BTCS, Inc. (BTCS), closed Tuesday's trading session at $0.0187, up 57.14%, on 14,432,797 volume with 437 trades. The average volume for the last 3 months is 1,909,108 and the stock's 52-week low/high is $0.01/$0.116.
The QualityStocks Company Corner
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
- TransCanna Holdings Inc. (CSE: TCAN)
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
- Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ)
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)
- Zenergy Brands, Inc. (ZNGY)
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4)
- Youngevity International, Inc. (NASDAQ: YGYI)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Earth Science Tech, Inc. (ETST)
- ChineseInvestors.com (CIIX)
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) was featured today in a look at what’s moving in the cannabis market. The Company announced earlier this month that it had entered into an agreement with CIBC Capital Markets and Eight Capital, under which the joint book runners agreed to purchase, together with a syndicate of underwriters, 11,500,000 subordinated voting shares of the company on a bought deal basis. The marijuana stock market shares much of its success from the recent boom taking place in the legal marijuana industry around the world. On a near daily basis, companies are entering the space with innovative approaches to how to best utilize the multitude of benefits presented by partaking in the use of recreational/medicinal cannabis.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $5.00, up 3.52%, on 782,200 volume with 1,454 trades. The average volume for the last 3 months is 508,433 and the stock's 52-week low/high is $2.40/$11.82.
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Named Among 4 Marijuana Stocks Gaining Speed On Tuesday (2/19/19)
- EU Parliament and WHO Could Blow the Lid off The Cannabis Sector: Who’s Ready for the Next Phase?
- Canopy Rivers to Report Third Quarter Fiscal 2019 Financial Results
TransCanna Holdings Inc. (CSE: TCAN)
TransCanna Holdings (CSE: TCAN) (FSE: TH8) will be hosting a corporate update conference call today, February 19, after the close of the market at about 1:15 PM PST. During the call, TCAN will provide an update on company activities since the IPO and discuss the company’s outlook moving forward, including opportunities TCAN is currently pursuing. To participate in the conference call, dial the Canada/USA toll free line at 1-800-319-4610 or the International line at +1-604-638-5340. The conference reference number is 10006275. To view the full press release, visit: http://nnw.fm/HL3l7.
TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.
California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.
TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.
TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.
TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.
As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.
Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.
The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.
For additional information, call: (604) 609-6199
TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $2.90, up 22.36%, on 436,406 volume with 279 trades. The stock's 52-week low/high is $0.77/$2.90.
- NetworkNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) to Provide Corporate Update in Conference Call
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Accepts Option to Buy Major California Site for Cannabis Operations
- TransCanna Announces the Completion of 420 Global
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
Automotive technology innovator Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) this morning announced that its QuadSight(TM) vision system was named a finalist in the prestigious 2019 Edison Awards in the Transportation & Logistics, Autonomous Vehicles category. To view the full press release, visit: http://nnw.fm/mzuA7.
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.
Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.
The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.
Foresight has developed three main products:
- QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
- Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
- Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.
In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.
Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.
Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.
Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.
Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $1.8002, up 3.94%, on 14,706 volume with 49 trades. The average volume for the last 3 months is 39,018 and the stock's 52-week low/high is $1.47/$4.47.
- NetworkNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) QuadSight(TM) Selected as 2019 Edison Awards Finalist
- NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Secures $1M Investment and Enters Binding Agreements, Strategic Development Alliance with RH Electronics
- Eye-Net Mobile Successfully Completes Initial Integration with the Assistance of a Leading Israeli Cellular Provider
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announce the appointment of Gary McMullen as Vice President, Napanee Operations. Mr. McMullen will assume his position effective March 4, 2019. Mr. McMullen joins VIVO with more than 20 years experience in the premium segment of the highly regulated brewing industry. As the president and founder of Muskoka Brewery, Mr. McMullen executed the company's strategy from production to sale. His deep roots in the Canadian craft brewing business also include his role as a founding member of the Canadian Association of Small Brewers and his eight-year tenure as Chairman of the Ontario Craft Brewers Association.
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.
“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.
VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.
VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.
This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.
VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.
VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.
Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.
With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.
VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.69, up 3.54%, on 241,047 volume with 144 trades. The average volume for the last 3 months is 378,213 and the stock's 52-week low/high is $0.413/$1.995.
- VIVO Cannabis Announces Appointment of Vice President, Napanee Operations
- VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly-Owned ABcann Medicinals
- 420 with CNW – Missouri Prosecutors Change Stance on Marijuana Cases
Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
An expansion of its leadership team is one of the steps that Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) has undertaken to solidify its top position as a cannabis beverage formulation company. In December 2018, Sproutly announced that Bryan Semkuley would be joining the company as president (http://nnw.fm/6VeSL).
Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.
To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.
This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.
Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.
Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.
Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.
Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.
President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.
Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.
Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.
Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.
Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.3052, up 5.24%, on 399,467 volume with 164 trades. The average volume for the last 3 months is 265,535 and the stock's 52-week low/high is $0.189/$1.875.
- Leadership Changes to Help Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) Become a Leading Cannabis Formulation Company
- Sproutly Provides Strategic Update
- Sproutly Announces Financial Results for the Third Quarter of 2018
QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)
Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) this morning announced that it has mobilized a diamond drill and support crew to the company’s wholly-owned Irgon Mine Project. The project is located in the prolific Cat Lake-Winnipeg River rare-element pegmatite field of S.E. Manitoba, which also hosts Cabot Corporation’s nearby Tantalum Mining Corporation of Canada (“TANCO”) rare-element pegmatite. To view the full press release, visit: http://nnw.fm/wtL4X.
QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.
QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.
The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.
North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.
The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.
QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens, and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.
The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.
QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.2214, up 3.46%, on 96,999 volume with 43 trades. The average volume for the last 3 months is 62,662 and the stock's 52-week low/high is $0.1155/$0.73.
- NetworkNewsBreaks – QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Mobilizes Diamond Drill and Support Crew to Irgon Lithium Mine Project
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Positioning Itself as Foremost Supplier to Global Lithium-Ion Battery Market
- NetworkNewsBreaks – QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) to Initiate Sampling Based on Soil Survey Results
BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)
BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) ("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, today announces it has been selected to present a poster at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium, held February 28–March 2, 2019, in San Francisco, California.
BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.
BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.
The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.
BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.
BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.
Breast Cancer Statistics
The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.
Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.
The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.
BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.075, up 3.02%, on 12,500 volume with 4 trades. The average volume for the last 3 months is 19,728 and the stock's 52-week low/high is $0.0495/$0.135.
- BriaCell to Present Clinical and Scientific Findings with New Insights at Key Oncology Conferences
- NetworkNewsBreaks – Newly Appointed Board of Directors Member Increases Beneficial Ownership of BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT)
- BriaCell Appoints Jamieson Bondarenko to its Board of Directors
Zenergy Brands, Inc. (ZNGY)
Zenergy Brands (OTC: ZNGY), a next-generation energy utility company, this morning announced its completion of the installation of a Zero Cost agreement with a Texas-based franchisee of a well-known fast food restaurant chain. Per the update, the deal is worth an aggregate contract value of $393,969.60 and the contract was first mentioned upon closing in 2018 and, at that time, disclosed in an 8K (http://nnw.fm/9OOmn). To view the full press release, visit: http://nnw.fm/dCSA7.
Zenergy Brands, Inc. (ZNGY) is a leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. The company’s vision is to converge smart controls (building automation) with energy conservation and retail energy to deliver comprehensive smart-energy service to customers. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions, and improve their bottom line.
The company’s cutting-edge Zero Cost Program™ reduces utility consumption by 20 to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to commercial, industrial, and municipal end-use customers. This financing mechanism allows customers to reduce water, natural gas, and electricity consumption by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program enriches businesses by immediately reducing energy consumption using smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management, and load factor correction.
A unique Managed Energy Services Agreement (“MESA”) permits Zenergy to retain a portion of these utility savings in exchange for financing the upgraded, retrofit equipment, and installation costs until a specified and agreed upon repayment period with the client ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 and 45 percent of total utility costs.
On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production.
According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025, which is where Zenergy will focus its efforts in 2019 and beyond. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.
Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0002, up 33.33%, on 32,337,376 volume with 29 trades. The average volume for the last 3 months is 126,699,780 and the stock's 52-week low/high is $0.000009/$0.013.
- NetworkNewsBreaks – Zenergy Brands Inc. (ZNGY) Completes Zero Cost Contract Installation with Franchisee of Well-Known Fast Food Restaurant Chain
- Zenergy Announces Joint-Marketing Agreement with National Consultancy — Energy Professionals
- Zenergy Announces the Closing of $1.6M in Initial Funding, as Tranche 1 of a $10 Million Debenture Facility
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)
Redfund Capital (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) recently announced the launch of its new beverage division. Per the update, Redfund Capital is filling a key gap in the market for lifestyle-driven infused beverages as demand for upscale hospitality and health-wellness sectors start to boom. To view the full press release, visit: http://nnw.fm/yhZ9i.
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.
As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.
The central components of the company’s business strategy are:
- Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
- Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.
Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.
Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.
The strategy employed by Redfund includes:
- Diversifying investments in Canada and other countries
- Building an international footprint with established national leaders
- Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
- Introducing companies to Canada as a viable option for public listings
- Becoming a premier go-to lender for established companies
The company’s revenue sources include:
- Interest-bearing debt instruments with asset-backed collateral to securitize loans
- Equity kicker of warrants coverage on original loan
- Conversion ability of loan in its entirety
- Advisory fees from contracts for consulting on growth strategies
- Right of first refusal on future financing in each company funded
Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.1873, even for the day. The average volume for the last 3 months is 207 and the stock's 52-week low/high is $0.10/$0.505.
- NetworkNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Announces Launch of its Beverage Products Division
- NetworkNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Welcomes Wahupta Ventures CEO to Advisory Team, Issues Corporate Update
- 420 with CNW – Marijuana Linked to Higher Sperm Concentrations
Youngevity International, Inc. (NASDAQ: YGYI)
Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced today that it completed the closing of the acquisition of all the assets of Khrysos Global–a Tampa, Florida based manufacturer of hemp-based CBD extraction equipment. Also today, CannabisNewsWire released a report featuring the company which examines how, as the cannabis sector consistently shows impressive growth, acquisitions within the market allow cannabis companies to develop greater vertical integration. The release reiterates how Youngevity is following a vertically integrated model, having recently acquired a company specializing in cannabis processing machinery.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $7.76, off by 0.89%, on 148,517 volume with 684 trades. The average volume for the last 3 months is 204,843 and the stock's 52-week low/high is $3.167/$16.25.
- YGYI Completes Acquisition of Assets of Khrysos Global, a Provider of End-to-End Processing Solutions for Hemp
- Savvy Companies Make Acquisition Moves in Booming Cannabis Industry
- CannabisNewsWire Announces Publication on Acquisitions Leading to Greater Vertical Integration in Thriving Cannabis Industry
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The agreement signed by The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) to supply cannabis to the Ontario Cannabis Retail Corporation marks another milestone on the company’s journey toward becoming the world’s leading organic cannabis brand (http://nnw.fm/0nyjF).
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.73, off by 4.21%, on 955,877 volume with 1,624 trades. The average volume for the last 3 months is 942,528 and the stock's 52-week low/high is $1.607/$7.894.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Clinches Deal to Supply Canada’s Largest Province
- NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Shows Potential to Become a Global Cannabis Industry Leader
- 420 with CNW – Consolidation Starts Taking Shape in the US Cannabis Industry
Earth Science Tech, Inc. (ETST)
Earth Science Tech (OTCQB: ETST), an innovative biotechnology company, recently displayed its leading-edge medical device Hygee(TM) at Arab Health 2019, the biggest annual medical trade fair in the Middle East and North Africa (“MENA”) region (http://nnw.fm/Jp7CD). To view the full article, visit: http://nnw.fm/Iqsh5.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.70, off by 2.78%, on 33,333 volume with 30 trades. The average volume for the last 3 months is 33,415 and the stock's 52-week low/high is $0.421/$2.45.
- NetworkNewsBreaks – Earth Science Tech Inc. (ETST) Displays Hygee at Arab Health 2019
- Earth Science Tech Inc. (ETST) Expands Distribution of Cannabidiol Line in Pharmaceutical and Healthcare Practitioner Spaces
- Earth Science Tech, Inc. Signs Distributor for Hygee™ and Provides Update on CBD Product Launch
ChineseInvestors.com, Inc. (OTCQB: CIIX) (the "Company"), an established financial news and investment education portal, and a leading industrial hemp retailer for the domestic Chinese-speaking community, today announced the completion of its rebranding of ChineseHempOil.com, Inc.'s consumer product line under the new opt brand. In conjunction with the rebranding, the Company announces the consolidation of its retail e-commerce sites into a single site, www.365CWC.com, providing busy consumers with a single platform intended drive overall sales. www.365CWC.com officially launches today.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed the day's trading session at $0.48, off by 2.04%, on 47,784 volume with 48 trades. The average volume for the last 3 months is 92,413 and the stock's 52-week low/high is $0.365/$1.25.
- ChineseInvestors.com, Inc.'s Wholly Owned Subsidiary ChineseHempOil.com, Inc. Announces Rebranding of its Consumer Product Line, Now the opt™ Brand
- ChineseInvestors.com Inc. (CIIX) on MoneyTV with Donald Baillargeon, 2/8
- ChineseInvestors.com Inc. (CIIX) to Seek Acquisition Target after CBD Biotech Spin-off
Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
Choom (CSE: CHOO; OTCQB: CHOOF) ("Choom") a Canadian cannabis retail company, is pleased to announce the completion of its e-commerce platform. Choom, through a licensed enterprise-level platform, has completed the buildout of a top tier e-commerce retail solution. This online storefront will provide a customized shopping experience that's integrated with Choom's retail stores and capable of scaling to $500M+ annually. Choom has ensured the platform's flexibility to compliantly handle both B2C and B2B sales to service and sell to any type of buyer in the cannabis industry.
Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.
Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.
True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.
Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.
A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.
While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.
Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.35, off by 1.33%, on 376,724 volume with 184 trades. The average volume for the last 3 months is 315,530 and the stock's 52-week low/high is $0.285/$1.13.
- Choom Completes Buildout of E-Commerce Platform
- Competition To Acquire State Cannabis Licenses Heating Up
- Choom Enters into LOI with Cannabis Retail Store Applicant
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Newly Appointed Board of Directors Member Increases Beneficial Ownership
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Reaffirms Economics of Shymanivske Project Based on Spike in Iron Ore Prices
- Cannabis Strategic Ventures, Inc. (NUGS) CannabisNewsAudio Announces Audio Press Release (APR) on Cannabis Strategic Ventures Takes Significant Step to Cater to California, Widen Operations
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) EU Parliament and WHO Could Blow the Lid off The Cannabis Sector: Who’s Ready for the Next Phase?
- ChineseInvestors.com (CIIX) MoneyTV with Donald Baillargeon, 2/8
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Competition To Acquire State Cannabis Licenses Heating Up
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Why Cool Events Is ‘One to Watch’
- Cyberfort Software, Inc. (CYBF) Tops List of Cybersecurity Stocks to Watch in 2019
- Earth Science Tech, Inc. (ETST) Expands Distribution of Cannabidiol Line in Pharmaceutical and Healthcare Practitioner Spaces
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) Closes Convertible Debenture Financing Totaling $4.8 Million
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Extends Mineralization at Iron Creek Project; Intersects High Grade Copper
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Provides Update on Refinery Material Testing Progress
- Generation Alpha, Inc. (GNAL) Partners with Seinergy LLC to Offer Lighting Rebates for U.S. Cannabis Growers
- Global Payout, Inc. (GOHE) MTrac System Sweeps The Nation With Proof of Concept, Showcases Revenue And Rapid Expansion
- Golden Developing Solutions, Inc. (DVLP) Where’s Weed Platform Teams Up with Cannabis Point-of-Sale Resource GreenBits
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Among Top Marijuana Stocks Are Showing Off New Tech
- Green Hygienics Holdings Inc. (GRYN) Maintains Position in Cannabis Markets through High Grade Product and Hydroponic Innovation
- Icon Exploration Inc. (TSX.V: IEX.H) Issues Update on Proposed Change of Business Transaction
- Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) Announces U.S. Listing on OTCQB Market Under Symbol KNRLF
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Subsidiaries Work to Secure New Deals for DehydraTECH in Various Industries
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Plans Second Program for Additional T.E.M and Follow Up Drilling on The Turi Prospect
- Marijuana Company of America Inc. (MCOA) Promotes Brand During Super Bowl and Hollywood Events
- Medical Cannabis Payment Solutions (REFG) 420 with CNW – Study Says Dabbing is the Most Efficient Way to Consume Cannabis
- MustGrow Biologics Corp. is “One to Watch”
- Net Element, Inc. (NASDAQ: NETE) Developing Unified Global Transaction Acceptance Ecosystem
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Non-Brokered Financing
- Pacific Software, Inc. (PFSF) Creating Foundation to Improve International Trade for South American Companies
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) 420 with CNW – Chronic Pain Tops Reasons for Medical Cannabis Use in America
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Announces an Increase to the Previously Announced Private Placement to $25 Million
- Pressure BioSciences Inc. (PBIO) Releases Video Demonstrating Capabilities of its Proprietary Ultra Shear Technology Platform
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Positioning Itself as Foremost Supplier to Global Lithium-Ion Battery Market
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Welcomes Wahupta Ventures CEO to Advisory Team, Issues Corporate Update
- Sharing Services, Inc. (SHRV) Expanding International Reach
- SinglePoint, Inc. (SING) CEO Discusses Acquisition Activity on MoneyTV with Donald Baillargeon
- Spectrum Global Solutions, Inc. (SGSI) Upcoming Agreement of Merger to Provide Unique Growth Opportunities
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Sproutly Provides Strategic Update
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) The Battery Race in the US and How Lithium Plays a Leading Role
- Sugarmade, Inc. (SGMD) to Exercise Option to Acquire BZRTH, LLC Further Expanding its Presence in Cannabis Supplies Sector
- Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) Continued Fiery Run Rate in Latest Fiscal Quarter
- Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology - QualityStocksNewsBreaks
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Focus on Producing Premium Cannabis Supported by Appointment of New Plant Science Director
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Shows Potential to Become a Global Cannabis Industry Leader
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) 420 with CNW – The Most Expensive Cannabis Product is Sold in Las Vegas
- TransCanna Holdings Inc. (CSE: TCAN) Accepts Option to Buy Major California Site for Cannabis Operations
- United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) Retracts Technical Disclosures
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Announces Cannabis Oil Sales License Granted to Wholly-Owned ABcann Medicinals
- Youngevity International, Inc. (NASDAQ: YGYI) CannabisNewsWire Announces Publication on Acquisitions Leading to Greater Vertical Integration in Thriving Cannabis Industry
- Zenergy Brands, Inc. (ZNGY) Announces Joint-Marketing Agreement with National Consultancy — Energy Professionals
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.